Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q2 2021 Ossur hf Earnings Call Transcript

Jul 22, 2021 / 07:00AM GMT
Release Date Price: kr48 (+1.27%)
Operator

Ladies and gentlemen, welcome to the Ãssur's Q2 2021 Results. Today, I am pleased to present Mr. Jon Sigurdsson, President and CEO; and Mr. Sveinn Solvason, CFO. (Operator Instructions)

Speakers, please begin.

Jon Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. I would like to thank -- I would like to welcome you to Ãssur investor conference call where we will cover the results for the second quarter of 2021. My name is Jon Sigurdsson, as previously mentioned, and I'm the President and CEO. And with me here today is Sveinn Solvason, our CFO. We will begin by going through the highlight of the quarter and ending with our guidance on 2021. A question-and-answer session will then follow.

Sales in the second quarter of 2021 amounted to $190 million, which correspond to 32% organic growth. The sales growth is high in Q2 as the comparison quarter was the most affected by COVID-19 last year. Sales continued to normalize in our key market, both in prosthetics and bracing & supports. The impact from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot